/SNANF
SNANF Stock - Sona Nanotech Inc.
Healthcare|Medical - Diagnostics & ResearchOTC
$0.35+1.46%
+$0.01 (+1.46%) • Dec 19
60
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.36
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.84
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.38
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SNANF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.34 – $0.35
TARGET (TP)$0.40
STOP LOSS$0.32
RISK/REWARD1:2.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.89
52W High$0.65
52W Low$0.17
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | $-457,000 | $-60,321 | $-65,594 | $-66,367 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-2,192 | $-2,380,000 | $-3,282,000 | $-10,803,000 | $-9,119,599 |
| Net Income | $-2,703,957 | $-2,500,000 | $-2,361,000 | $-10,367,000 | $-6,272,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.03 | $-0.03 | $-0.03 | $-0.16 | $-0.10 |
Company Overview
Sona Nanotech Inc., nanotechnology life sciences company, manufactures and sells gold nanorod products for diagnostic tests. The company also provides Nanotech COVID-19 Lateral Flow Assay, an immunochromatographic assay for the detection of the spike protein antigen from SARS-CoV-2 in saliva specimens from individuals, who are suspected of COVID-19; Gemini gold nanorods; Omni gold nanorods for medical applications; and contract services. Its products are used in various applications, including drug delivery, food and beverage testing, environmental testing, cell imaging, cancer treatment, and liposuction therapy, as well as medical and consumer, military, and veterinary diagnostics. The company is based in Halifax, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
SNANFBeat Rate
100%
Last 2 quarters
Avg Surprise
+36.0%
EPS vs Estimate
Beats / Misses
2/0
Last 12 quarters
Latest EPS
$-0.01
Q3 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q2 24
No data
Q3 24
No data
Q1 25
No data
Q1 25
No data
Q2 25
+43.8%
$-0.01vs$-0.01
Q3 25
+28.2%
$-0.01vs$-0.01
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 30, 2026 | — | — | — | — |
Q1 2026 | Feb 25, 2026 | — | — | — | — |
Q3 2025 | Sep 29, 2025 | $-0.01 | $-0.01 | +28.2% | ✓ BEAT |
Q2 2025 | Jun 27, 2025 | $-0.01 | $-0.01 | +43.8% | ✓ BEAT |
Q1 2025 | Mar 31, 2025 | — | $-0.01 | — | — |
Q1 2025 | Feb 26, 2025 | — | $-0.00 | — | — |
Q3 2024 | Jul 31, 2024 | — | $-0.01 | — | — |
Q2 2024 | Apr 29, 2024 | — | $-0.01 | — | — |
Q2 2024 | Apr 26, 2024 | — | $-0.01 | — | — |
Q1 2024 | Jan 30, 2024 | — | $-0.01 | — | — |
Q3 2023 | Jul 31, 2023 | — | $-0.01 | — | — |
Q2 2023 | Apr 30, 2023 | — | $-0.00 | — | — |
Q1 2023 | Jan 31, 2023 | — | $-0.00 | — | — |
Q4 2022 | Oct 31, 2022 | — | $0.01 | — | — |
Q3 2022 | Jul 31, 2022 | — | $-0.01 | — | — |
Q2 2022 | Apr 30, 2022 | — | $-0.02 | — | — |
Q1 2022 | Jan 31, 2022 | — | $-0.01 | — | — |
Q4 2021 | Oct 31, 2021 | — | $-0.02 | — | — |
Q3 2021 | Jul 31, 2021 | — | $-0.03 | — | — |
Q2 2021 | Jun 29, 2021 | — | $-0.04 | — | — |
Latest News
Loading news...
Frequently Asked Questions about SNANF
What is SNANF's current stock price?
Sona Nanotech Inc. (SNANF) is currently trading at $0.35 per share. The stock has moved +1.46% today.
What is the analyst price target for SNANF?
No analyst price targets are currently available for this stock.
What sector is Sona Nanotech Inc. in?
Sona Nanotech Inc. operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the OTC exchange.
What is SNANF's market cap?
Sona Nanotech Inc. has a market capitalization of $0.04 billion, making it a small-cap company.
Does SNANF pay dividends?
No, Sona Nanotech Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACHFF
Arch Biopartners Inc.
$0.89
Mkt Cap: $0.1B
AIRDF
Rocket Doctor AI Inc.
$0.52
Mkt Cap: $0.0B
CLTEF
Calliditas Therapeutics AB (publ)
$0.55
Mkt Cap: $0.0B
DBCCF
Decibel Cannabis Company Inc.
$0.08
Mkt Cap: $0.0B
ETST
Earth Science Tech, Inc.
$0.16
Mkt Cap: $0.0B
FLOOF
Flower One Holdings Inc.
$0.00
Mkt Cap: $0.0B
PCNEF
Precision System Science Co., Ltd.
$2.28
Mkt Cap: $0.1B
PLNH
Planet 13 Holdings Inc.
$0.24
Mkt Cap: $0.1B
VICP
Vicapsys Life Sciences, Inc.
$1.50
Mkt Cap: $0.0B
ZIVO
ZIVO Bioscience, Inc.
$9.98
Mkt Cap: $0.0B
Explore stocks similar to SNANF for comparison